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Summary Study objectives: Recently, we demonstrated significantly improved
baroreflex sensitivity (BRS) and autonomic balance after 31% supplemental oxygen
(SuppO2) in resting patients with chronic obstructive pulmonary disease (COPD). In
order to investigate whether peripheral arterial stiffness changes may play a role, we
evaluated changes in peripheral arterial stiffness and BRS after SuppO2.
Design: Single blinded crossover design.
Setting: Pulmonary exercise testing laboratory.
Participants: Seventy subjects with moderate to severe COPD.
Interventions: We measured arterial vascular stiffness using the augmentation
index via contour analysis of the radial pulse obtained from applanation tonometry.
BRS was derived using the sequence method before and after treatments with
compressed air (CA) and 30% SuppO2 in 70 individuals with COPD via a counterbalanced
crossover design.
Results: Paired t-tests indicated significant differences in oxygen saturation (SaO2)
following SuppO2 when compared to CA ( %x 96.072.0% SuppO2 versus %x 92.673.6% CA,
Po0:001). BRS was significantly greater following SuppO2 compared to CA (%x
3.572.3ms/mmHg SuppO2 versus %x 3.172.1 CA ms/mmHg, Po0:03). Vascular
stiffness was significantly increased with SuppO2 when compared with CA (%x
13.376.1% SuppO2 versus %x 10.874.9% CA, Po0:001).
Conclusions: Our findings indicate that oxygen supplementation ameliorates BRS by
changes in vasomotor activity. The amelioration of the BRS into a more normal range
is a move towards the restoration of more normal physiology.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Vascular stiffness has been shown to be sensitive to
vasomotor activity changes in large and small
arteries. This vasomotor activity is in part mediated
via baroreflex sensitivity (BRS) and its modula-
tion.1–5 Recently, our laboratory demonstrated, in a
crossover double-blind study, that supplemental
oxygen (SuppO2) significantly improved BRS in
resting patients with moderate and severe chronic
obstructive pulmonary disease (COPD).6 A possible
mechanism for this improvement could be through
altered vascular stiffness. Oxygen and carbon
dioxide modulate vasomotor activity in peripheral
arteries via constriction and vasodilation, respec-
tively. It is clear that oxygen supplementation can
act as a vasoconstrictor in individuals with primary
pulmonary hypertension, congestive heart failure
and normal controls.7–10 Furthermore, evaluation
of autonomic indices in these studies revealed an
alteration of the baroreflex responses and heart
rate variability.9–10 This relationship has not been
investigated in COPD.
In order to investigate whether peripheral
vascular stiffness changes following oxygen supple-
mentation play a role in the favorable autonomic
indices we had seen previously, we evaluated
peripheral vascular stiffness in individuals with
COPD in response to oxygen supplementation. In
addition, we investigated whether changes in
vascular stiffness were associated with changes
in BRS in patients with COPD.
Materials and methods
Subjects
In the period from September 1999 to September
2000, 82 patients with severe COPD who were
referred for exercise testing to our laboratory were
screened for entry into the study. Out of those
potential subjects a total of 70 patients had normal
baseline electrocardiograms (ECGs) and consented
to participate in this randomized double-blind
crossover study. The study was carried out in the
Human Performance Laboratory of the College of
Physicians and Surgeons of Columbia University.
The study was approved by the Institutional Review
Board of the New York Presbyterian Hospital, and
all subjects gave informed consent before partici-
pating. Subject demographic characteristics are
presented in Table 1. Baseline arterial blood gasses
and pulmonary function tests are presented in
Table 2. All subjects were instructed to maintain
their daily routine activity and medications
throughout the entire study.
Study protocol
A multilead ECG (Marquette Medical Systems:
Milwaukee, WI), and respiration via a temperature
sensor (YSI reusable temperature probe: Yellow
Springs, OH) placed under the subject’s nostril
were recorded. Beat-to-beat radial artery blood
pressures and pressure wave contours were re-
corded via an arterial tonometer (model 7000:
Colin Medical Instruments: San Antonio, TX) at-
tached to the subject’s wrist. Once the artery is
located, the pressure transducer was placed over
the vessel and depressed on the artery against
underlying bone.11,12 The bone provides a contact
force between the skin and the sensor approximat-
ing intra-arterial pressure (Fig. 1).12 The contact
force is converted to an electrical signal by the
transducer, providing a continuous beat-to-beat
recording. The signal was sampled at 200 Hz/
channel with an analog-to-digital (A/D) converter
(DAQ-700, National Instruments, Austin, TX) and
channeled into a Dell Pentium Computer. The
brachial artery blood pressure was also measured
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Table 1 Demographic profile of subjects.
Age 62.8 (8.5)
BMI 23.8 (3.9)
percent male 50%
All values are reported as mean (standard deviation).
Table 2 Pulmonary parameters of included sub-
jects.
FEV1 0.78 (0.37)
%FEV1 30.4 (13.3)
FVC 2.04 (0.83)
%FVC 56.4 (18.8)
MVV 33.0 (15.3)
%MVV 31.7 (13.7)
Room air ABG pH 7.42 (0.04)
Room air ABG pO2 66.4 (11.9)
Room air ABG pCO2 41.8 (8.9)
All values are reported as mean (standard deviation).Ab-
breviations: FEV1Fforced expiratory volume at 1 s; %
FEV1Fpercent predicted FEV1; FVCFforced vital capa-
city; %FVCFpercent predicted FVC; MVVFmaximum
voluntary ventilation; %MVVFpercent predicted MVV;
ABGFarterial blood gas.
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with the cuff at heart level on the right arm
using auscultation. Pulse oximetry was recorded
using an index finger pulse oximeter (Sat-Trak
Pulse Oximeter 767589-103; SensorMedics; Yorba
Linda, CA). All subjects equilibrated to the
environmental conditions while seated with the
light dimmed for approximately 15min. While
at rest subjects were instructed to maintain
breathing at 12 breaths/min and were instructed
to do so through the use of a pacing light
box. Control for breathing rate is recommended
since breathing rate has an entrainment effect
on RR interval spectra.13 To remove bias, a
Venturi mask was placed on each patient and the
patient received either 31% SuppO2 or compressed
air (CA) in a random order. Randomization was
based on the patient’s hospital identification
number (odd number¼ oxygen first/CA second;
even number¼CA first/oxygen second). After
equilibration, a 5min data collection was per-
formed. Then the gas mixture was switched to the
alternate mixture, and after a 15min equilibration,
another 5min of data were collected. Total test
duration was approximately 40min (two trials with
equilibration on the alternative gas mixture in
between).
Data acquisition
All bio-potentials were channeled through an
interface board (BNC 2080, National instruments
Co., Austin TX) and fed into a 12-bit A/D converter
(DAQCard-700, National instruments Co., Austin
TX) and then into a Pentium computer (Hitachi
Vision Book Plus, San Jose, California). All data
collection epochs were 5min in duration, which is
in accordance with the standards put forth by the
European Task Force on Standards of Heart Rate
Variability Procedures.14 Post acquisition data
analyses were performed off-line.
Data Analysis
Baroreceptor sensitivity assessment
Baroreceptor sensitivity was derived from the 5-
min epoch of collected data. The R–R intervals
were delineated via a peak detection algorithm as
described previously.15 The spontaneous BRS was
determined as the slope between the change in
systolic blood pressure and the change in phase of
the R–R intervals by a modification of the technique
of Bertinieri et al.16 Linear regression is performed
on any episode of three consecutive beats with R–R
interval lags in the same direction (either up or
down), and the resultant data yield an evaluation
of the BRS.15
The augmentation index
The digitized pulse pressure waveform was ana-
lyzed using a customized LabView program. Speci-
fically, an algorithm detects the waveform’s
inflection point on the upstroke; this inflection is
considered to signal the onset of the reflected
wave.16 The augmentation index (AI), a noninvasive
marker of vascular stiffness, was then calculated as
the ratio of amplitude of the pressure wave above
its systolic shoulder to the total pulse pressure.12
Validity and reliability of this method has been
demonstrated against invasively obtained pressure
signals.17
Statistical analysis
Paired t-test comparisons were made between the
two treatments for all dependent variables and a
probability of Po0:05 was considered significant.
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Figure 1 A plot of the AI, with the individual arterial
blood pressure waveforms on the top, and a plot of the
averaged waveforms on the bottom. The third derivative
of the waveform below, with the inflection points marked
for identification. The AI is calculated at the point
indicated at the crosshairs.
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Results
No significant differences were seen in breathing
rates between the two treatments. Following
oxygen supplementation (SuppO2), significant dif-
ferences were seen in oxygen saturation levels
(SaO2) when compared to CA ( %x 96.072.0% SuppO2
versus %x 92.673.6% CA, Po0:001). BRS was
significantly greater following supplemental oxygen
( %x 3.572.3ms/mmHg SuppO2 versus %x 3.172.1ms/
mmHg CA) when compared to CA (Po0:005)
(Fig. 2).
Arterial stiffness as measured by the AI was
significantly increased with SuppO2 ( %x 13.376.1%
SuppO2 versus %x 10.874.9% CA) when compared
with CA (Po0:001) (Fig. 3).
Discussion
The results of our investigation indicate that acute
oxygen supplementation in patients with COPD
significantly altered arterial vascular stiffness along
with BRS at rest. Prior research has shown that
patients with COPD have a reduced BRS.6,18
Furthermore, it has been suggested that the
attenuation in baroreflex response was mainly due
to systemic hypertension;18 however, no clear
physiologic explanation for this observation has
been provided. The findings of increased peripheral
vascular stiffness with a corresponding increase in
BRS have been documented in congestive heart
failure patients.9 Additionally, increases in vascular
stiffness have been seen in both obliterative
pulmonary vascular disease7 and normal indivi-
duals.8,10 The findings in the current investigation
suggest that SuppO2 in COPD leads to an increase in
arterial vascular stiffness, and this is associated
with an acute enhancement of spontaneous BRS. In
our subjects, there was a significant increase in the
SaO2 with SuppO2 compared to CA. This would be in
agreement with both the known vasodilator effects
of mild hypoxemia and the vasoconstrictor effects
of oxygen supplementation.7–10,19–22 Thus, acute
SuppO2 appears to result in a relative vasoconstric-
tion with a resultant restoration of vascular tone
throughout the peripheral arterial vascular tree in
patients with long-standing COPD. This increase in
arterial vascular tone probably results in a narrow-
ing of the lumen of arteries which, at nearly equal
blood pressure, will cause an earlier stretching and
stimulation of the carotid baroreceptors. This
increase in stimulation of the baroreceptors will
result in a compensatory increase in vagal outflow,
causing a decrease in arterial pulse pressure and
heart rate along with changes in sympathetic and
parasympathetic tone that our group has previously
reported.6 These findings of increased parasympa-
thetic activity in response to hyperoxia has been
described in normal individuals as well.10 The
overall direction of this response may be an
increased parasympathetic modulation and de-
creased sympathetic modulation.
The clinical importance of the findings in the
current investigation is in the role vascular stiffness
plays in baroreflex modulation. Our findings of
increased arterial vascular stiffness were seen
following oxygen supplementation in moderately
hypoxic individuals. Although there are several
studies demonstrating an increase in peripheral
vascular tone and pressure in response to hyperox-
ia, we are unaware of studies exploring the
consequences on vascular stiffness of converting
mild hypoxemia to normoxemia. The physiological
benefits of the use of SuppO2 in individuals with
chronic hypoxemia have not been clearly eluci-
dated, yet clear survival benefits have been
documented in the long-term oxygen treatment
trial and nocturnal oxygen treatment trial
studies.22,23 The relationship of pulmonary
hypertension and increased mortality are
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Figure 2 Vascular reactivity as measured by BRS in
individuals with COPD on and off of SuppO2.
Figure 3 Vascular stiffness as measured by the AI in
individuals with COPD on and off of SuppO2.
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established, but the mechanisms by which chronic
oxygen supplementation is protective are not clear.
In patients with primary pulmonary vascular ob-
literative disease, hyperoxia leads to decreased
cardiac output, decreased stroke volume, and
decreased pulmonary pressures without a change
in vascular tone.7 In individuals with no fixed
pulmonary hypertension, increased BRS, and the
subsequent increase in parasympathetic modula-
tion, may be important modulating factors in
attenuating the progression to the development
of pulmonary hypertension. Eckberg and coworkers
found that mild hypoxia in which arterial SaO2 was
reduced by 0.1% repeatedly lead to parasympa-
thetic withdrawal.20 Our prior findings corroborate
this by showing evidence that SuppO2 augments
parasympathetic tone.6 In addition to hypoxemia,
COPD patients often have hypercapnia which may
further exacerbate autonomic disturbances via
synergistically increased sympathetic activity.21,24
Because of the possible effects of hypercapnea, the
respiratory rate was controlled in the current
investigation so that no differences in respiratory
frequencies were seen between treatments.12 This
had the effect of standardizing the effects of
respiratory rate on efferent cardiac-autonomic
activity.
In summary, our findings strongly suggest that
oxygen supplementation acutely ameliorates BRS
via changes in arterial vasomotor activity in
individuals with COPD. The vasoreactivity in the
peripheral arteries appears to be preserved,
allowing for an improved vasomotor regulation
and improvement in the BRS in response to SuppO2.
The clinical significance of improvement in the BRS
has been shown in post-myocardial patients, where
loss of BRS is a major risk factor for future
cardiovascular morbidity and mortality.25 It re-
mains to be seen whether chronic enhancement
of arterial tone and BRS with SuppO2 may lead to
improved clinical outcomes.
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